Summary: Experimentica Oy announces the appointment of a new Managing Director. The current CEO will transition to the role of Executive Chairman.

Content
Kuopio, Finland — January 24th, 2025 — Experimentica Ltd., a leading preclinical CRO in the ocular space, is thrilled to announce the appointment of Dr. Jukka Puoliväli as the new Managing Director. With over 20 years of experience in the contract research field, Dr. Puoliväli is poised to lead the organization in its mission to deliver innovative solutions to its clients.
In a planned transition, Dr. Giedrius Kalesnykas will take on the role of Executive Chairman, guiding the Board of Directors while ensuring a seamless shift in leadership that aligns with the company’s strategic objectives. This decision comes after a comprehensive search for a candidate whose vision aligns with Experimentica’s mission of excellence in contract research.
“I am genuinely excited to join Experimentica and eager to help realize its vision in the coming years,” said Dr. Puoliväli. “With the advancements the company has made, especially regarding R&D in ocular preclinical modeling and implementation of AI tools for image analysis, I see immense potential for growth and innovation”.
Dr. Kalesnykas expressed his confidence in the new hire’s capability to lead the organization, stating, “The decision to bring Jukka on board was not made lightly. We have sought a leader who not only possesses extensive experience but also shares our commitment to align with Experimentica’s strategic objectives. We believe that Jukka will execute the necessary changes that foster company’s growth and further expansion, reinforcing our position as a leader in the preclinical ocular market.”
Experimentica Ltd. is dedicated to leveraging cutting-edge technologies and innovative strategies that position it as a frontrunner in the contract research industry. The integration of novel non-invasive methodologies for ocular research and new AI tools for enhanced image analysis reflects the company’s commitment to staying at the forefront of research capabilities.
For more information about Experimentica Ltd. and its latest developments, please contact:
Guillaume Demarne, PharmD
Chief Business Officer
gd@experimentica.com
+33 7 83 55 69 52
About Experimentica Ltd.
Experimentica Ltd. is a leading contract research organization dedicated to providing tailored research solutions for ocular drug discovery. With a commitment to innovation and R&D excellence, Experimentica utilizes state-of-the-art technology to deliver accurate and timely results to its clients.
About Dr. Jukka Puoliväli
Dr. Jukka Puoliväli earned his PhD in Neuroscience in 2000 from the University of Kuopio, Finland. He then pursued post-doctoral research at the Department of Neuroscience and Neurology at the University of Kuopio before joining the Gladstone Institutes of Neurological Disease at UCSF in San Francisco, where he worked as a post-doctoral researcher from 2002 to 2004. With over 50 peer-reviewed publications to his name, Dr. Puoliväli currently holds the position of Adjunct Professor of Behavioral Neuroscience at the University of Eastern Finland.
After returning to Kuopio in 2004, Dr. Puoliväli spent more than 20 years at Charles River Discovery Research Services, where he held various roles and gained extensive experience in the contract research organization field.